Skip to main content

Table 4 Adverse events

From: DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study

Events

Sitagliptin

Voglibose

 

n = 29

n = 34

Diarrhea

0 (0%)

1 (2.9%)

Nausea

0 (0%)

1 (2.9%)

Edema

0 (0%)

2 (5.9%)

Abdominal fullness

0 (0%)

1 (2.9%)

  1. Number of cases (%) is shown.